Skip to main content
Year archive

Vicore Pharma Holding — 2022 filings

All 38 regulatory filings released by Vicore Pharma Holding (VICO) in 2022, sourced directly from the official regulator.

38 Filings
2022 Period
2022 filings (38)
Filing Released Lang
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2022-12-30 Swedish
Increase of number of shares and votes in Vicore Pharma
Share Issue/Capital Change
2022-12-30 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-12-09 English
Vicore har genomfört en riktad nyemission av 10 000 000 aktier till en teckningskurs om 20 kronor per aktie och tillförs en bruttolikvid om 200 miljoner kronor
Capital/Financing Update
2022-12-08 Swedish
Vicore has carried out a directed share issue of 10,000,000 shares at a subscription price of SEK 20 per share, raising gross proceeds of SEK 200 million
Capital/Financing Update
2022-12-08 English
Vicore avser att genomföra en riktad nyemission av aktier
Capital/Financing Update
2022-12-07 Swedish
Vicore intends to carry out a directed share issue
Share Issue/Capital Change
2022-12-07 English
Vicore announces new data from the IPF AIR trial further strengthening the benefit-risk profile of C21
Earnings Release FY 2022
2022-11-03 English
Vicore meddelar nya resultat från IPF studien AIR som ytterligare stärker nytta-riskprofilen hos C21
Earnings Release FY 2022
2022-11-03 Swedish
Delårsrapport juli-september 2022
Interim / Quarterly Report 9M 2022
2022-11-03 Swedish
Interim report July-September 2022
Interim / Quarterly Report Q3 2022
2022-11-03 English
Vicore offentliggör valberedningen inför årsstämman 2023
Board/Management Information
2022-10-20 Swedish
Vicore announces the Nomination Committee for the 2023 Annual General Meeting
Board/Management Information
2022-10-20 English
Vicore ger en uppdatering av ATTRACT-3 studien i COVID-19
Earnings Release FY 2022
2022-09-15 Swedish
Vicore provides an update on the ATTRACT-3 COVID-19 trial
Regulatory Filings
2022-09-15 English
Delårsrapport april - juni 2022
Interim / Quarterly Report Q2 2022
2022-08-25 Swedish
Interim report April - June 2022
Interim / Quarterly Report Q2 2022
2022-08-25 English
Interim / Quarterly Report 2022
Interim / Quarterly Report H1 2022
2022-08-25 Swedish
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2022-06-30 Swedish
Increase of number of shares and votes in Vicore Pharma
Share Issue/Capital Change
2022-06-30 English
Vicore beslutar om en kvittningsemission om 87 686 aktier som del av milstolpesersättning
Share Issue/Capital Change
2022-06-17 Swedish
Vicore resolves on a set-off issue of 87,686 shares as part of milestone compensation
Share Issue/Capital Change
2022-06-17 English
Kommuniké från årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2022-05-11 Swedish
Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2022-05-11 English
Interim report January - March 2022
Interim / Quarterly Report Q1 2022
2022-05-05 English
Delårsrapport januari - mars 2022
Interim / Quarterly Report Q1 2022
2022-05-05 Swedish
Kallelse till årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2022-04-07 Swedish
Notice of annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2022-04-07 English
Annual Report 2021
Annual Report FY 2021
2022-04-07 Swedish
Annual Report 2021
Annual Report FY 2021
2022-04-07 English
Michael Wolff Jensen resigns from the Vicore board of directors and is replaced by Jacob Gunterberg as chairman of the board up until the annual general meeting in May 2022
Board/Management Information
2022-03-23 English
Michael Wolff Jensen utträder ur Vicores styrelse och ersätts av Jacob Gunterberg som styrelseordförande för perioden fram till årsstämman i maj 2022
Board/Management Information
2022-03-23 Swedish
Year-end report 2021
Interim / Quarterly Report Q4 2021
2022-02-25 English
Bokslutskommuniké 2021
Earnings Release Q4 2021
2022-02-25 Swedish
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-02-21 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-21 Swedish
Vicore’s AIR study interim analysis suggests that C21 improves lung function in IPF patients
Earnings Release FY 2022
2022-02-10 English
Interimsanalys av Vicores AIR-studie visar att C21 förbättrar lungfunktionen hos IPF patienter
Regulatory Filings
2022-02-10 Swedish